# Xtrackers MSCI World Health Care UCITS ETF (XWHS) **Page:** https://fundology.uk/fund/xwhs · ISIN IE00BM67HK77 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, XWHS (Xtrackers MSCI World Health Care UCITS ETF, ISIN IE00BM67HK77) closed at £51.83 on the London Stock Exchange. Its ongoing charge is 0.25% a year (about £25 on £10,000). Over the five years to 13/11/2026 its total return was +39.2%, or +8.6% after UK CPIH inflation. ## Summary Xtrackers MSCI World Health Care UCITS ETF is an exchange-traded fund (ETF) from Xtrackers, launched in 2010. It tracks the MSCI World Index / Health Care -SEC — about 1,300 large and medium-sized companies in 23 developed countries, around 70% of it in the US. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.25% a year — about £25 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£51.83** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | XWHS | | ISIN | IE00BM67HK77 | | Also listed as | XDWH (London Stock Exchange, US dollars) | | Category | Healthcare | | Type | ETF | | Provider | Xtrackers | | Tracks | MSCI World Index / Health Care -SEC | | Income | Accumulating | | Ongoing charge | 0.25% a year (£25 per £10,000) | | Fund size | £3.4bn | | Launched | 2010 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 04/03/2016 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +19.59% | +15.35% | income reinvested | | 3 years | +36.06% | +22.93% | income reinvested | | 5 years | +39.16% | +8.62% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Xtrackers MSCI World Health Care UCITS ETF in pounds (price, with income reinvested in the fund): 2024 +4.2%, 2025 +5.2%; 2026 to 13/11/2026 +19.3%. Returns of Xtrackers MSCI World Health Care UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +13.8%; to 30/09/2025: −4.5%; to 30/09/2024: +9.8%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2024 | +4.2% | +0.7% | Price | | 2025 | +5.2% | +1.6% | Price | | 2026 to 13/11/2026 | +19.3% | +15.5% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 16.22% | -10.59% | | 3 years | 13.98% | -17.80% | ## Largest fall Volatility of Xtrackers MSCI World Health Care UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 16.2% over 1 year, 14.0% over 3 years. Largest fall in the price of Xtrackers MSCI World Health Care UCITS ETF since August 2023, in pounds: −17.8% from 30/08/2024 to 23/05/2025. The lowest 12-month return of Xtrackers MSCI World Health Care UCITS ETF in pounds (price, with income reinvested in the fund) since August 2023 was −16.3% (12 months to 08/08/2025); the highest was +23.2% (12 months to 07/08/2026). On 13/11/2026 the price of Xtrackers MSCI World Health Care UCITS ETF was at its highest weekly close since August 2023, in pounds. ## Charges compared with similar funds Ongoing charge of Xtrackers MSCI World Health Care UCITS ETF 0.25% a year. Compared on 14/11/2026, 18 of the 28 other healthcare funds charge more, 0 the same and 10 less (share classes counted once). ## Funds tracking the same index 2 funds track MSCI World Index / Health Care -SEC, this one included and share classes counted once; their ongoing charges range from 0.25% to 0.30% a year (13/11/2026). | Fund | Ongoing charge | 1 year | 3 years | 5 years | |---|---|---|---|---| | Amundi MSCI World Health Care UCITS ETF EUR ACC | 0.30% | +17.9% | +35.9% | +38.2% | | Xtrackers MSCI World Health Care UCITS ETF (this fund) | 0.25% | +19.6% | +36.1% | +39.2% | Returns are as reported, in pounds, income reinvested unless marked "(price)". ## Charges & eligibility - Ongoing charges figure (OCF): **0.25%** per year - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds As of 15/11/2026, XWHS holds 115 positions, according to its published holdings. The largest is Eli Lilly at 12.14% of the fund; the ten largest make up 47.9%. ### Top holdings Largest positions (as of 15/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | Eli Lilly | [LLY](https://fundology.uk/stock/LLY) | 12.14% | | 2 | Johnson & Johnson | [JNJ](https://fundology.uk/stock/JNJ) | 7.25% | | 3 | AbbVie | [ABBV](https://fundology.uk/stock/ABBV) | 5.53% | | 4 | UnitedHealth Group | [UNH](https://fundology.uk/stock/UNH) | 3.91% | | 5 | Merck | [MRK](https://fundology.uk/stock/MRK) | 3.86% | | 6 | Roche | [RO](https://fundology.uk/stock/RO) | 3.63% | | 7 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 3.13% | | 8 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 2.96% | | 9 | Thermo Fisher Scientific | [TMO](https://fundology.uk/stock/TMO) | 2.76% | | 10 | Amgen | [AMGN](https://fundology.uk/stock/AMGN) | 2.68% | ## Where it invests Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed. ### By sector Added up from the fund’s published holdings, as of 15/11/2026. | Sector | Weight | |---|---| | Health Care | 98.1% | | Other funds | 1.8% | | Not classified | 0.1% | ### By country Added up from the fund’s published holdings, as of 15/11/2026. | Country | Weight | |---|---| | United States | 72.4% | | Switzerland | 9.1% | | United Kingdom | 4.6% | | Japan | 3.2% | | France | 2.0% | | Denmark | 1.9% | | Other funds | 1.8% | | Germany | 1.5% | | Other countries | 3.4% | | Not classified | 0.1% | ### By type of asset Added up from the fund’s published holdings, as of 15/11/2026. | Type of asset | Weight | |---|---| | Equity | 98.1% | | Cash and money market | 1.9% | The 112 holdings on record (of 115 reported): https://fundology.uk/fund/xwhs/holdings ## Questions people ask **What is the ongoing charge of XWHS?** The ongoing charge of XWHS is 0.25% a year — about £25 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Xtrackers MSCI World Health Care UCITS ETF 0.25% a year. Compared on 14/11/2026, 18 of the 28 other healthcare funds charge more, 0 the same and 10 less (share classes counted once). **What does XWHS track?** XWHS tracks the MSCI World Index / Health Care -SEC — about 1,300 large and medium-sized companies in 23 developed countries, around 70% of it in the US. **Is XWHS accumulating or distributing?** XWHS is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of XWHS?** The ISIN of XWHS is IE00BM67HK77. An ISIN identifies one exact share class of a fund; XWHS is its ticker on the London Stock Exchange. The same share class is also listed as XDWH (London Stock Exchange, US dollars). **What does XWHS hold?** As of 15/11/2026, XWHS holds 115 positions, according to its published holdings. The largest is Eli Lilly at 12.14% of the fund; the ten largest make up 47.9%. Its ten largest holdings are Eli Lilly (12.14%), Johnson & Johnson (7.25%), AbbVie (5.53%), UnitedHealth Group (3.91%), Merck (3.86%), Roche (3.63%), Novartis (3.13%), AstraZeneca (2.96%), Thermo Fisher Scientific (2.76%) and Amgen (2.68%). **What were XWHS’s returns in each of the last five years?** Calendar-year returns of XWHS in pounds (price, with income reinvested in the fund): 2024 +4.2%, 2025 +5.2%; 2026 to 13/11/2026 +19.3%. Past performance is not a guide to future returns. **How has XWHS done after inflation?** Over the five years to 13/11/2026 XWHS’s total return was +39.2%, or +8.6% after UK CPIH inflation. Past performance is not a guide to future returns. ## Fund documents - [Fund page at Xtrackers (DWS)](https://etf.dws.com/en-gb/IE00BM67HK77-msci-world-health-care-ucits-etf-1c/) - Links checked 12/10/2026. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.